Form D · Private Equity Fund
Abingworth Clinical Co-Development Co-Investment Fund, L.P.
Washington, DC · CIK 0001986436
Offering snapshot reported Nov 17, 2023 · SEC filing
- Reported sold
- $346M Indefinite offering
- Investors reported
- 18 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Aug 25, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
- Reported investors0 → 18
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 17, 2023 | Amendment | $346,405,000 | No comparison | 18 | SEC filing |
| Aug 21, 2023 | Initial | Yet to sell | No comparison | 0 | SEC filing |
Offering details
- Securities
- Pooled investment fund
- Exemptions
- 06b, 3C, 3C.7
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $595K (estimated)
- Finders' fees
- $0
- Form D file number
- 021-490264
Total amount sold includes commitment from the feeder fund.
Sales commission includes amounts earned with respect to CCD-CIF Holdings, L.P.
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| TCG Capital Markets L.L.C. | 291767 | TCG Capital Markets L.L.C. · CRD 291767 |
| Asante Capital Group Advisors, LLC | 155178 | Asante Capital Group Advisors, LLC · CRD 155178 |
Source: Form D, filed Nov 17, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
Each card uses that adviser's latest imported filing. Filing dates can differ; these disclosures do not confirm a current relationship.
Matched by reported Form D file number
ABINGWORTH BIOVENTURES 9
Investment adviser: CARLYLE INVESTMENT MANAGEMENT L.L.C.
- Gross asset value
- $63.8M
- Beneficial owners
- 98
- ADV minimum commitment
- $25M
Reported in Form ADV on Jul 7, 2026. Fund assets and beneficial owners measure different things from Form D sales and investors.
Service providers
Provider details
- Annual audit
- Yes
- Prime brokers
- No
- Custodians
- Yes
- Administrator other than the adviser
- No
- External marketing
- Yes
ERNST & YOUNG LLP
PCAOB 42
TCG CAPITAL MARKETS L.L.C.
CRD 291767 · SEC 8-70061
Fund asset history · 3 annual observations
Scroll to see all columns →
| Fiscal year | Gross assets | Beneficial owners | ADV filed |
|---|---|---|---|
| 2023 | $0 | 10 | Mar 27, 2024 |
| 2024 | $14,174,978 | 10 | Mar 31, 2025 |
| 2025 | $63,789,888 | 98 | Mar 31, 2026 |
Filing source
Form ADV 2115592 · Jul 7, 2026 · Schedule D 7.B.(1), fund 805-1258408468
Reported by CARLYLE INVESTMENT MANAGEMENT L.L.C. (CRD 111128).
Other-Than Anual Amendment For Registered Adviser.
Official IAPD profile (latest public filing). Historical values on this page come from the SEC/IAPD filing archive; the public profile may show a newer filing.
Matched by reported Form D file number
ABINGWORTH CLINICAL CO-DEVELOPMENT CO-INVESTMENT FUND
Investment adviser: CARLYLE INVESTMENT MANAGEMENT L.L.C.
- Gross asset value
- $158M
- Beneficial owners
- 55
- ADV minimum commitment
- $25M
Reported in Form ADV on Jul 7, 2026. Fund assets and beneficial owners measure different things from Form D sales and investors.
Service providers
Provider details
- Annual audit
- Yes
- Prime brokers
- No
- Custodians
- Yes
- Administrator other than the adviser
- No
- External marketing
- No
ERNST & YOUNG LLP
PCAOB 42
Fund asset history · 3 annual observations
Scroll to see all columns →
| Fiscal year | Gross assets | Beneficial owners | ADV filed |
|---|---|---|---|
| 2023 | $57,510,287 | 40 | Mar 27, 2024 |
| 2024 | $75,033,386 | 40 | Mar 31, 2025 |
| 2025 | $157,976,829 | 55 | Mar 31, 2026 |
Filing source
Form ADV 2115592 · Jul 7, 2026 · Schedule D 7.B.(1), fund 805-5336050518
Reported by CARLYLE INVESTMENT MANAGEMENT L.L.C. (CRD 111128).
Other-Than Anual Amendment For Registered Adviser.
Official IAPD profile (latest public filing). Historical values on this page come from the SEC/IAPD filing archive; the public profile may show a newer filing.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Jeremy Anderson | Executive |
| N/A Ccd Cif General Partner, L.P. | Promoter |
| N/A Ccd Cif, L.L.C. | Promoter |
| Christina Gibbs | Executive |
| Elizabeth Muscarella | Executive |
Issuer details
Industry: Pooled Investment Fund (See others in industry)
Address:Washington, DC, 20004
Phone: 202-729-5626